Antibiotic Sensitivity Testing PDF
Document Details
Tags
Summary
This document provides an overview of antibiotic sensitivity testing, including attributes of ideal antimicrobial agents, side effects, range of effectiveness, and mechanisms of action. It includes tables and diagrams. This is for an undergraduate course in pharmacology or microbiology.
Full Transcript
**[Antibiotic Sensitivity Testing]** **Attributes of an Ideal Antimicrobial Agent** - Selective toxicity - What ideal antimicrobial agents exhibit (drug is harmful to a pathogen without being harmful to the host) - Relative rather than absolute (dug in a concentration toler...
**[Antibiotic Sensitivity Testing]** **Attributes of an Ideal Antimicrobial Agent** - Selective toxicity - What ideal antimicrobial agents exhibit (drug is harmful to a pathogen without being harmful to the host) - Relative rather than absolute (dug in a concentration tolerated by the host may damage an infecting microorganism) - Targets: - Receptors not found in host - Biochemical pathways not essential for host - Soluble in bodily fluids - Non-allergenic - Reasonable half-life - Long shelf life - Inexpensive **Side Effects** - Toxicity - Drugs may be toxic to kidneys, liver, or nerves - Considerations needed when prescribing drugs to pregnant women - Disruption of normal microbiota **Range of Effectiveness of Antibiotics** - Broad spectrum - Works on a wide range of bacteria and pathogens - More likely to disrupt microbiota or off target effects - Narrow spectrum - Increased selection, reduce non-selective toxicity - More information needed **Antibiotics Mechanism of Action** +-----------------------------------+-----------------------------------+ | Cell component | Inhibitor of synthesis | +===================================+===================================+ | Cell wall | Beta-lactams | | | | | | - Penicillins | | | | | | - Cephalosporins | | | | | | Other | | | | | | - Vancomycin | +-----------------------------------+-----------------------------------+ | Protein | Anti-50S | | | | | | - Inhibits peptide chain | | | elongation during protein | | | synthesis | | | | | | - Bind 23S rRNA subunit | | | | | | Anti-30S | | | | | | - Interfere directly and | | | causing misreading of mRNA | +-----------------------------------+-----------------------------------+ | Nucleic acid | DNA | | | | | | - Inhibit DNA gyrase and | | | topoisomerase, blocking DNA | | | replication | | | | | | RNA | | | | | | - Interferes with bacterial | | | DNA-dependent RNA polymerase | +-----------------------------------+-----------------------------------+ | Cell membrane | Example: Polymyxin B | | | | | | - Binds to plasma membrane and | | | increases its permeability, | | | while disrupting its | | | structure | +-----------------------------------+-----------------------------------+ | Metabolites | Antimetabolite antibiotics | | | | | | - Inhibitors of folic acid | | | synthesis | | | | | | - Important for many | | | functions including | | | growth and RNA/DNA | | | synthesis | | | | | | - Examples: sulfonamides & | | | trimethoprim | | | | | | - Inhibitors of mycolic acid | | | synthesis | | | | | | - Specific for mycobacteria | | | as it is the major lipid | | | component of their cell | | | walls | | | | | | - Example: isoniazid | +-----------------------------------+-----------------------------------+ **Goals of Antibiotics** - Bactericidal - Kills bacteria - Can be bacteriostatic at low concentrations - Bacteriostatic - Stops bacterial growth - If removed bacteria can continue to grow - Requires the hosts immune system to kill the bacteria **Measurement of Antimicrobial Activity** - Conventional susceptibility testing: +-----------------------------------+-----------------------------------+ | Broth Dilution Testing | - Range of concs for each | | | antibiotic is a series of | | | doubling dilutions | | | | | | - Concentration range of drugs | | | depends on specific criteria | | | | | | - The MICs are then translated | | | into: | | | | | | - Susceptible, | | | intermediate, or | | | resistant (based on | | | correlation between MIC | | | with serum-achievable | | | levels) | | | | | | - Types: macrodilutions (2 mL) | | | and microdilutions (100 uL) | | | | | | Advantages | | | | | | - Quantitative method | | | | | | - Straightforward | | | | | | - Opportunity for automation | | | | | | - Flexible | | | | | | Disadvantages | | | | | | - Time consuming and tedious | | | | | | - Media usage | | | | | | - Possibility of error | +===================================+===================================+ | Agar Dilution Testing | - Serial dilutions of the | | | antibiotic are added to | | | melted solid media, poured | | | and left to cool and solidify | | | | | | - Involves a series of agar | | | plates each containing a | | | different concentration of | | | antibiotic | | | | | | - Then a fixed number of | | | organisms is inoculated on | | | the surface of agar plates, | | | and examined by colony count | | | after incubation | | | | | | Advantages | | | | | | - More gradual changes | | | | | | Disadvantages | | | | | | - Labor intensive | | | | | | - Expensive | | | | | | - Space inefficient | +-----------------------------------+-----------------------------------+ | Disc Diffusion Method | - Bacterial suspension should | | | be standardized | | | | | | - Concentration of antibiotics | | | in the disk should be | | | standardized (provided from | | | the manufacturer) | | | | | | - Incubation time and | | | temperature should be | | | standardized | | | | | | - Standardized agar medium | | | (most used is Mueller-Hinton | | | agar) | | | | | | Protocol | | | | | | 1. Make bacterial lawn | | | | | | 2. Dispense antibiotic disks | | | | | | 3. Press GENTLY with forceps for | | | disks to adhere. | | | Alcohol-flame forceps to | | | sterilize | | | | | | 4. Label plates on the edges | | | | | | 5. Invert plates and incubate | | | | | | Zone of Inhibition | | | | | | - Measure from the center of | | | the disk to a point on the | | | circumference of the zone, | | | multiply by 2 | | | | | | Advantages | | | | | | - Simple, flexible, reduced | | | labour, inexpensive, | | | consistent | | | | | | Disadvantages | | | | | | - Diameter instead of | | | concentration requires | | | interpretation | | | | | | - Qualitative | | | | | | - Limited antibiotics | +-----------------------------------+-----------------------------------+ | Epsilometer Test (E-test) | Advantages | | | | | | - Potentially more consistent | | | and accurate | | | | | | - Relatively easy | | | | | | - Well controlled antibiotic | | | concentrations | | | | | | Disadvantages | | | | | | - Higher costs (\~10x cost of | | | discs) | | | | | | - Limited number of antibiotics | +-----------------------------------+-----------------------------------+ - Automated antimicrobial susceptibility testing - Terms - **Minimum inhibitory concentration** (MIC): the lowest antimicrobial concentration that completely inhibits visible growth of an organism - **Minimum bactericidal concentration** (MBC): the lowest antimicrobial concentration required to kill a particular bacterium **Determining Minimum Bactericidal and Inhibitory Concentrations** A diagram of different types of liquid Description automatically generated **Standardization** - The potential influence of environmental factors on antibiotic activity should be minimized - Conditions for susceptibility testing are standardized in the following reasons: - Optimized growth conditions inhibition of growth is due to antimicrobial agent - Optimized integrity of antimicrobial failure to inhibit growth is the organisms' resistance mechanisms, not environment inactivation - Reproducibility and consistency in the resistance profile **Standardized Components of Antimicrobial Susceptibility Testing** - Time 16 hours - Concentrations of antimicrobial 2-fold dilution series - Total volume 2 mL for microdilution; 100 uL for microdilution - Initial inoculum concentration 0.5 McFarland scale or 0.08-0.12 at 625 nm == 1 x 10^5^ CFU/mL **Limitations of Standardization** - In vivo environment cannot be reproduced, where the actual interaction between the bacteria and antibiotic will take place - Other factors - Antibiotic diffusion into tissues and host cells - Serum protein binding of antimicrobial agents - Status of patient immune system - Virulence of the infecting bacterium **Automated Antimicrobial Susceptibility Testing** - Automatically generates a growth curve based on readings - Algorithm-derived MIC +-----------------------------------+-----------------------------------+ | Test | Description | +===================================+===================================+ | Vivtek System | - Micro plate 'card' with | | | preloaded antibiotics | | | | | | - Photometric measurements | | | | | | - Tests against a standard to | | | reach appropriate turbidity | +-----------------------------------+-----------------------------------+ | MicroScan | - Standard micro-dilution test | | | trays | | | | | | - Fluorometric measurements | +-----------------------------------+-----------------------------------+ | BD Phoenix | - Oxidation-reduction detector | | | and a turbidity measurement | +-----------------------------------+-----------------------------------+ - Advantages - Less tedious - More reproducible - Fast - Automated data output - Disadvantages - Limited types of antimicrobials - Limited ability to detect some forms of antimicrobial resistance - Expensive **How are breakpoints calculated/selected?** - All testing requires breakpoints (AKA interpretive criteria), so that the results of the tests can be interpreted and reported as: +-----------------------------------+-----------------------------------+ | Susceptible | Indicates that the antimicrobial | | | agent may be an appropriate | | | choice (in this | | | | | | situation). Bacterial resistance | | | is absent or clinically | | | insignificant. | +===================================+===================================+ | Intermediate | Indicates a number of | | | possibilities, including: | | | | | | - The potential utility of the | | | agent in the body sites where | | | it may be concentrated | | | | | | - The response rates may be | | | lower than those susceptible | | | isolates | | | | | | - Providing a "buffer" between | | | the resistant and susceptible | | | categories to prevent serious | | | interpretive errors | +-----------------------------------+-----------------------------------+ | Resistant | Indicates that the isolates are | | | not inhibited by the usually | | | achievable concentrations of the | | | agent with normal dosage | | | schedules and/or demonstrates | | | that the MICs/Zone diameters that | | | fall in the range where the | | | specific microbial resistance | | | mechanisms are likely and that | | | clinical efficacy against the | | | isolates has not been shown | | | reliably in treatment studies | +-----------------------------------+-----------------------------------+ - Depending on the method, breakpoints are expressed as either a concentration or a zone diameter **"Scattergram" of MICs vs Zone Diameters to Determine Breakpoint for Zone Diameter** - Horizontal lines are drawn from the MIC resistant breakpoint and the susceptible MIC breakpoint - Where the horizontal lines intersect the regression line, vertical lines are drawn to delineate the corresponding inhibitory zone size breakpoints in mm **Breakpoints Categories** - In the category intermediate, has multiple purposes: - "Strains with MICs in the given range is too small to derive robust conclusions" - Responses can be variable - May be dose dependent - Fills in the grey area between resistant and susceptible **Selection of Antimicrobial Agents for Lab Testing** - Agents chosen for testing are antimicrobial batteries or panels - Content and application of each battery based on: - Organisms' identification or group - Acquired resistance patterns common to local microbial flora - Site of infection **Dangers of Indiscriminate Use** - Indications for administration of antibiotic must be qualified by concerns: - Changes in the normal flora of the body, with disease resulting from "superinfection" due to overgrowth of drug-resistant organisms - Direct drug toxicity - Development of drug resistance in microbial populations, chiefly through the elimination of drug-sensitive microorganisms from antibiotic-saturated environments and their replacement by drug-resistant microorganisms **All antibiotic orders must have:** - When to take them - How much to take How many days you should take them